BeStock  
Stocks › NAMS

NewAmsterdam Pharma NAMS

US equityMarket cap rank #2565Biotechnology
$22.80 −$0.40 (-1.72%)
Pre-market · Oct 6, 8:40 am ET · After hours $22.80 0.00%
Open$22.84
Prev close$23.20
Day range$22.23 – $23.34
Volume1.18M
Market cap$2.73B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$52.75+131.4% vs. price
  • Buy 100%
Low $42.00Now $22.80Avg $52.75High $60.00

Recent rating changes

The last 20 actions on file set price targets from $42.00 to $60.00, averaging $52.87.

DateFirmRatingTarget
5 Oct 2026 RBC Capital BUY $42.00
2 Oct 2026 Wells Fargo BUY $55.00
29 Sep 2026 H.C. Wainwright BUY $52.00
22 Sep 2026 Truist Financial BUY $57.00
21 Sep 2026 BMO Capital BUY $58.00
21 Sep 2026 H.C. Wainwright BUY $52.00
18 Sep 2026 William Blair BUY –
8 Sep 2026 Truist Financial BUY –
8 Sep 2026 Stifel BUY $50.00
8 Sep 2026 H.C. Wainwright BUY $52.00
7 Aug 2026 Needham BUY $48.00
6 Aug 2026 William Blair BUY –
6 Aug 2026 Truist Financial BUY –
6 Aug 2026 Stifel BUY $50.00
6 Aug 2026 H.C. Wainwright BUY $52.00
5 Aug 2026 BMO Capital BUY $58.00
5 Aug 2026 RBC Capital BUY $50.00
4 Aug 2026 Piper Sandler BUY $60.00
27 Jul 2026 Truist Financial BUY $57.00
24 Jul 2026 William Blair BUY –

Discussion

No comments yet — be the first to weigh in on NAMS.

Leave a comment

Scroll to Top